glp-1 weight regain Regained Within 18 Months of Stopping Drugs GLP-1 Medication for Weight Loss:

It is possible that studies with negative or non-significant results were less likely to be published, which could lead to an overestimation of treatment effects

8 (9), E1323

Despite this, GLP-1RA also exert a significant benefit on HF which suggests their use when SGLT-2 inhibitors are contraindicated or not tolerated

This approach can greatly inform further clinical studies and improve patient outcomes. The findings were published in Diabetes, Obesity and Metabolism, with Liang Yiwen, a PhD student from the School of Public Health at HKUMed, as the first author

HRTS is managed by an experienced portfolio management team and is supported by a scientific board, that includes a GLP-1 pioneer